Nasus Pharma Ltd
No financial data available for NSRX.
Company may not file with SEC or CIK is unresolved.
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | 2026-04-22 | Teleman Dan Benjamin | Director & Chief Executive Officer | Purchase | 2,900 | $3.76 | $11K | 157.0K | View | |
| 2026-03-31 | 2026-04-01 | Teleman Dan Benjamin | Director & Chief Executive Officer | Purchase | 15.0K | $2.04 | $31K | 21.2K | View |
Informational purposes only, not investment advice.